Bangladesh vs Philippines: Access to anti-retroviral drugs, male
Bangladesh
45.0%
in 2024
Philippines
42.0%
in 2024
Bangladesh rank
125th
Philippines rank
128th
Access to anti-retroviral drugs, male over time
- Bangladesh
- Philippines
How they compare
Bangladesh currently reports 45.0% against 42.0% in Philippines, a difference of 3.0%.
That makes Bangladesh's figure about 1.1 times Philippines's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Philippines ahead.
Bangladesh ranks 125th and Philippines ranks 128th of 141 countries.
Philippines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9% | 1.3% | 0.4% | Philippines |
| 2010s | 13.0% | 21.5% | 8.5% | Philippines |
| 2020s | 36.4% | 41.4% | 5.0% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bangladesh or Philippines?
- Bangladesh, at 45.0% against 42.0% in Philippines as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bangladesh and Philippines?
- 3.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Philippines rank globally for access to anti-retroviral drugs, male?
- Bangladesh ranks 125th and Philippines ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.